The Network Effect: Life Settlements as a Connective Tissue in Financial Markets

Introduction: The Network Effect

Life settlements — the secondary market sale of life insurance policies — have evolved from a little-known niche into a unique alternative asset class that links disparate corners of the financial ecosystem. In essence, a life settlement allows an investor to purchase a senior’s life insurance policy, pay the remaining premiums, and eventually receive the death benefit. This simple transaction creates a network effect that ripples across domains: it connects capital markets with individual longevity and healthcare outcomes, bridges the needs of an aging population with the search for yield, and aligns with social responsibility goals. Like connective tissue, life settlements bind these domains, making the whole financial system more robust and intertwined in surprising ways.

What sets life settlements apart is their low correlation with traditional markets and their attractive, bond-like cash flows. The return on a life settlement investment depends on actuarial timing (when policies mature) rather than economic cycles. Historically, policy yields have averaged in the high single digits annually — about 8% in one long-term study — compared to ~5.5% for equities and ~7% for corporate bonds ( ). Yet these returns showed virtually zero correlation to stocks or bonds ( ). In other words, life settlements generate returns from an entirely different underlying driver (human longevity) than stocks (corporate earnings or GDP) or bonds (interest rates). This distinctive source of risk and return allows life settlements to function as a financial connective tissue : they plug into portfolios to enhance diversification, even as they channel funds into healthcare and retirement needs.

Healthcare-Finance Nexus

One of the most intriguing aspects of life settlements is how they link the world of healthcare with the world of finance. The performance of a life settlement investment is directly longevity-linked — returns are realized when an insured individual passes away. This means that an investor’s financial outcomes depend on healthcare outcomes in a very literal sense. Improvements in medical treatment, preventive care, or health trends that extend life expectancy will delay policy maturities and can lower near-term returns, whereas health crises or faster mortalities can accelerate returns. In effect, life settlements tie financial performance to the trajectory of biomedical science and public health. Few asset classes have this kind of connection. By monetizing longevity risk, life settlements create a feedback loop between capital markets and healthcare: investors have a stake in understanding (and predicting) medical advances, and the healthcare industry indirectly feels the influence of capital market pricing of longevity.

This healthcare-finance nexus is sparking innovation in how we model and manage longevity risk. The life settlement industry employs advanced actuarial models and even emerging technologies like digital twins to forecast individual health outcomes ( ). The need for accurate life expectancy forecasting in life settlements has driven investment in big data and medical underwriting techniques that parallel those in cutting-edge healthcare analytics ( ) ( ). In turn, these predictive models can inform insurers and healthcare providers about longevity trends, creating a two-way flow of insight. When a new drug or preventive therapy emerges, life settlement investors quickly update their models — effectively translating healthcare progress into financial risk metrics.

Importantly, life settlements also channel funds into healthcare and wellness for seniors. Policy sellers are typically older adults who opt to sell an unneeded or unaffordable policy. The lump sum they receive (often several times higher than the insurer’s cash surrender offer ( )) can be used for medical expenses, long-term care, or other health-related needs. Thus, life settlements forge a new link between healthcare outcomes and financial performance by directly financing seniors’ healthcare. A senior who sells a life policy can pay for better treatment or assisted living, potentially improving their quality of life (and even longevity) thanks to investor capital. In aggregate, this trend may encourage greater investment in preventive care — for instance, seniors with more liquidity are more likely to afford medications and early interventions, which can lead to better health outcomes. One study noted a positive correlation between seniors’ economic health and physical well-being: those with more financial security (which life settlement proceeds can provide) are less likely to delay doctor visits or skip medications ( ). In this way, life settlements act as a conduit , turning financial assets into healthcare funding. Over time, widespread use of life settlements could influence insurance pricing models as well. Insurers, knowing there is a secondary market valuing longevity risk, might adapt how they price premiums or design policies (for example, incorporating more flexible surrender options) to stay competitive. The bottom line is that life settlements entwine the fates of healthcare and finance — capital flows now directly respond to epidemiological and medical trends, and seniors’ health decisions are increasingly influenced by financial innovation.

Intergenerational Wealth Transfer

As societies age, the efficient transfer of wealth and resources across generations becomes paramount. Life settlements have emerged as a powerful tool to enhance capital efficiency in aging populations and facilitate intergenerational wealth transfer . At their core, life settlements unlock value for policyholders (typically seniors) that would otherwise be lost. In the absence of a secondary market, a senior who no longer needs or can afford a life insurance policy has two poor choices: lapse the policy (letting it expire worthless) or surrender it to the insurer for a modest cash value. Either way, the senior and their family lose out on the bulk of the policy’s benefit, and the insurer reaps a windfall. Life settlements introduce a much better third option: sell the policy to an investor for a fair market value. This allows the individual to realize a significantly higher portion of the policy’s face value — on average, 7 to 8 times the cash surrender value, according to industry data ( ). Researchers from London Business School estimated that the secondary market pays about four times more than insurers for the same policies ( ). The value that was locked in an illiquid insurance contract is thus liberated and can be put to productive use by the senior or their heirs.

The network effect extends to public finances as well. By providing private funding for seniors’ needs, life settlements can reduce reliance on government programs and ultimately benefit younger generations of taxpayers. A striking analysis showed that in 2017, Americans over age 65 lapsed or surrendered life insurance policies with a total face value of $148 billion ( ). If even a fraction of those had been settled, an estimated $26.6 billion could have gone back to seniors’ pockets (assuming typical discount rates) ( ) — money that could pay for healthcare, housing, or bequeathments. This figure actually exceeds the entire $20.6 billion that U.S. seniors spent on long-term care and home health that year ( ). In other words, the potential of the life settlement market, if fully realized, could cover much of the funding gap for elderly care . Indeed, one policy think-tank noted that if the secondary market reached full capacity, the investment flowing to seniors would meet or surpass the amount needed to bridge Medicare’s gaps in outpatient and long-term care coverage ( ). By unlocking such vast sums, life settlements enable older generations to support themselves without exhausting the resources of younger generations. Adult children may not need to dip into their own savings to support aging parents who have monetized a policy, and any remaining settlement proceeds can effectively act as a living inheritance — helping grandchildren with education or other needs while the original policyholder is still alive to see it.

In summary, life settlements grease the wheels of intergenerational capital flow . They turn illiquid, often overlooked insurance assets into cash that supports the elderly, relieves families, and even lightens the load on public entitlement systems. In an era where a massive wealth transfer from Baby Boomers to younger cohorts is underway, life settlements serve as a pragmatic tool to optimize that transfer. They ensure that the wealth tied up in life insurance — an estimated $20 trillion of coverage in force in the U.S. ( ) — can find its way to where it’s needed most, at the right time.

Life settlements also check the box on the Governance aspect. The industry in the U.S. is heavily regulated at the state level, with consumer protection laws in place in over 90% of the population’s jurisdictions ( ). Standardized contracts, disclosures, and fiduciary duties are enforced to ensure fair transactions. This regulatory framework has been strengthened over time to weed out past abuses and ensure ethical conduct. For investors, the governance factor is about transparency and accountability in how life settlement funds operate — something that top managers take seriously, given the long-term nature of the asset. Many life settlement funds incorporate rigorous internal controls (e.g. independent medical evaluations, legal due diligence on policies ( )) and adhere to best practices that align with strong governance principles.

In summary, life settlements align with ESG considerations by delivering social value (financial inclusion and support for an aging population) and operating under robust governance structures. Investors with ESG mandates increasingly acknowledge this. They see that alongside generating uncorrelated returns, a life settlement fund can have a meaningful positive impact on individuals’ lives. Few alternative assets can claim to turn a profit and potentially save someone’s home or pay for their life-saving surgery. Life settlements inhabit that rare intersection, making them an unlikely but powerful ESG ally in modern portfolios.

Mathematical and Market Analysis

Beyond the qualitative benefits, life settlements offer a compelling quantitative profile that has attracted sophisticated investors. From a portfolio construction standpoint, they combine high risk-adjusted returns with low correlation, and their unique risk can be modeled and managed with actuarial precision. In this section, we delve into the numbers and modeling techniques that underpin this asset class, highlighting why the asset’s statistical profile is so attractive.

Crucially, diversification works in life settlements just as it does in other asset classes. A larger, well-diversified pool of policies dramatically reduces idiosyncratic risk (the risk of one unusually long-lived individual skewing results). According to research, as portfolio size increases, the variance of the portfolio IRR decreases markedly ( ). Intuitively, this is the Law of Large Numbers: one policy’s outcome might be highly uncertain, but across 100 or 1,000 policies, actual maturities will converge toward the statistical averages. This is why institutional life settlement funds hold hundreds of policies — to turn longevity risk into something closer to a predictable mortality curve at scale. The diversification benefit means that an investor in a large fund faces much lower volatility than an investor in a single policy. In fact, while an individual life settlement can be quite binary (either a very high return if the insured dies early, or a low return if they live long), the portfolio behaves more like a fixed-income instrument with a spread . The cash flows are akin to a portfolio of zero-coupon bonds with uncertain maturities, but aggregated, the uncertainty smooths out considerably.

Another invaluable attribute is near-zero market correlation . This holds especially true during market stress. In the 10 worst months of equity performance, a representative life settlements fund actually delivered an average +0.9% gain , while equities (ASX200 index in this case) fell an average of 7.0%. In other major drawdowns like 2020 or 2022, life settlement funds famously preserved capital or even notched positive returns, because their cash flows are driven by mortality events, not economic distress.

Comparison of life settlements to traditional assets,

For portfolio strategists, these traits make life settlements a powerful diversifier. In mean-variance optimization terms, adding a slice of life settlements can improve the efficient frontier of a portfolio. Even a small allocation (on the order of 3–5%) in a 60/40 stock-bond portfolio has been shown to reduce overall volatility and increase Sharpe ratio ( ). The optimal weight will depend on investor risk tolerance (since life settlements are somewhat illiquid and have a longer duration), but the message is clear: life settlements provide alpha (excess return) and beta diversification at the same time. They behave unlike any other asset — indeed longevity risk has very low beta to the market — yet compensate investors with a healthy yield for bearing that risk. This combination of high-yield/low-correlation is the “holy grail” that asset allocators seek to stabilize and enhance portfolio performance.

In summary, the math supports the inclusion of life settlements as a unique alternative asset. Through rigorous stochastic modeling, managers can navigate the actuarial uncertainties; through diversification, they tame volatility; and through careful portfolio integration, investors can harvest an uncorrelated return stream with strong risk-adjusted returns . The numbers reinforce the narrative: life settlements are not just anecdotally different — they are statistically distinct and valuable in the context of a multi-asset portfolio.

Macro Trends and Future Outlook

On the demand side , several macro factors are driving institutional investors toward life settlements. One is the persistent search for yield in a low-rate world — even after recent interest rate hikes, many investors remain underwhelmed by traditional fixed-income yields especially on a risk-adjusted basis. Life settlements offer yields that can match private equity or high-yield debt, but without correlation to economic cycles. This is increasingly attractive in a time when the 60/40 portfolio has faced challenges. The year 2022 was a wake-up call: simultaneous double-digit losses in equities and bonds broke the traditional diversification model ( ). In the aftermath, investors large and small started looking more seriously at uncorrelated assets to buffer against such periods. Life settlements stood out in that chaos, as they weathered the financial storm of 2022 with little to no drawdown . Because life settlement valuations are tied to actuarial discount rates, which did not spike erratically, and there were few forced sellers, the asset class held its value even as virtually everything else fell. This performance has bolstered confidence and sparked fresh interest: many family offices and institutional allocators who had been sitting on the sidelines are now exploring allocations to life settlement funds for the first time. Higher general interest rates actually make life settlements relatively more appealing on a portfolio level — if inflation remains a threat, assets like LS that are not hurt by inflation (and might even benefit if higher inflation shortens some lifespans or increases the cost of waiting) can be a good hedge in a way bonds cannot.

Another macro trend is the continued maturation and institutionalization of the life settlement industry. A decade ago, life settlements were dominated by specialty players and had a reputation for opacity. Today, the ecosystem includes established fund managers, market indices, dedicated longevity risk hedging instruments, and more stringent regulation — all hallmarks of a maturing asset class. The entry of institutional capital (pension funds, endowments, etc.) is increasing liquidity and professionalism in the market. We are also seeing technological improvements: the use of blockchain for tracking policy ownership, AI and machine learning to refine life expectancy estimates, and digital platforms connecting policy sellers with bidders. These advancements will likely reduce transaction costs and improve pricing accuracy over time, making the market more efficient and accessible. As processes streamline, more policies can flow through the pipeline effectively, and investors can have greater confidence in the integrity of the asset (with clear chain-of-ownership, etc.).

Importantly, investor sentiment toward life settlements is very positive , suggesting a bright outlook. In a recent 2023 survey of institutional investors already in insurance-linked securities (including life settlements), 44% reported they plan to increase their allocation to life settlements in the coming year, compared to just 12% planning to decrease ( ). Once investors enter the asset class and understand its dynamics, they tend to maintain or boost their exposure — a testament to the strong performance and diversification benefits they’ve experienced. This momentum is likely to continue as the asset class earns a more prominent place in alternative investment portfolios. We may even see life settlements included in multi-asset benchmark indices or packaged in new forms (for example, as tradable securities or via securitizations) which could further broaden the investor base.

Looking to the future, several secular themes support the expanding role of life settlements. The retirement funding shortfall is a global issue — as highlighted by the data that 80% of Americans fall short of conservative retirement savings targets ( ) — and life settlements provide one piece of the solution by freeing up otherwise stranded capital. Additionally, as longevity risk becomes a focal point (for governments worried about pension solvency, for insurers managing old blocks of business, and for families facing uncertain lifespans), having a vibrant life settlement market is a form of societal risk transfer. It takes longevity risk that was concentrated on individuals and insurers, and disperses it to investors willing to bear it for a price. This broader distribution of longevity risk can make the overall financial system more resilient to aging-related shocks. In the same way that catastrophe bonds spread out natural disaster risk, life settlements spread out the financial consequences of people living longer or shorter than expected. We can expect further financial innovation at this intersection of longevity and capital markets — for instance, the development of longevity swaps, mortality derivatives, or hybrid products that combine life settlements with other insurance-linked exposures. EverOak Innovations (the firm behind this research) and peers are continually refining strategies to harness these opportunities, from proprietary modeling (leveraging stochastic simulations and AI) to novel fund structures that appeal to a wider array of investors.

In conclusion, life settlements are increasingly functioning as the connective tissue of financial markets : connecting the investment community with real demographic and health outcomes, connecting seniors’ needs with global capital, and connecting the dots between high finance and social impact. Their low correlation and reliable returns improve portfolios; their payouts improve lives. As macro trends of aging and demand for alternatives continue, life settlements are set to grow in prominence and scale. We expect them to become a standard part of the toolkit for asset allocators seeking true diversification and strong risk-adjusted yields. In doing so, life settlements will continue to weave together the fabric of finance and society — an embodiment of the network effect in action, where each link strengthens the whole. This burgeoning asset class not only offers a compelling investment case but also stands as a beacon of financial innovation serving human needs, proving that sometimes the best opportunities lie at the intersection of networks that were once separate .

Originally published at https://www.linkedin.com.